全球疟疾流行病学研究进展

刘巧; 刘珏

doi:10.11847/zgggws1139898

全球疟疾流行病学研究进展

doi: 10.11847/zgggws1139898

刘巧,
刘珏^,

北京大学公共卫生学院流行病与卫生统计学系，北京 100191

基金项目: 国家自然科学基金（72122001）；科技部对发展中国家科技援助项目（KY202101004）

详细信息

作者简介:
刘巧（1998 – ），男，重庆人，硕士，研究方向：传染病流行病学

通讯作者:
刘珏， E-mail：jueliu@bjmu.edu.cn

中图分类号: R 183.5
计量
- 文章访问数: 51
- HTML全文浏览量: 20
- PDF下载量: 27
- 被引次数: 0
出版历程
- 接收日期: 2022-07-29
- 网络出版日期: 2023-03-31
- 刊出日期: 2023-04-10

A review on advances in global malaria epidemiology

LIU Qiao,
LIU Jue^,

Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China

摘要

摘要: 疟疾为全球主要公共卫生问题之一，世界卫生组织于2021年认证中国成功消除本土疟疾病例，但中国仍面临境外输入疟疾并在本土造成传播的风险。有必要充分认识全球疟疾流行情况、疟疾对健康的危害以及如何控制疟疾，从而评估我国疟疾输入风险，巩固消除疟疾的成果。本文就全球疟疾流行病学研究进展进行综述，介绍中国2017 — 2021年输入性疟疾流行情况、全球疟疾流行情况、疟疾对健康的影响以及控制疟疾的措施。
- 疟疾 /
- 流行病学 /
- 输入风险
Abstract: Malaria is one of major global public health problems. Although China′s success in eliminating indigenous malaria cases having been recognized by World Health Organization in 2021, China is still at risk of imported malaria from abroad and local transmission of the disease. Therefore, it is necessary to fully understand global malaria epidemic and to assess the risk of imported malaria in China for consolidating the achievement of malaria elimination. In this paper, we reviewed research progress in global malaria epidemiology, malaria-related health risk, malaria prevention and control measures, and imported malaria epidemic from 2017 through 2021 in China.
- malaria /
- epidemiology /
- risk of imported malaria

HTML全文

表 1 2017 — 2021年报告输入性疟疾病例数

年份	输入病例	临床诊断	恶性疟	间日疟	三日疟	卵形疟	诺氏疟	混合感染
2017^[10]	2858	9	1819	573	67	352	1	37
2018^[11]	2671	5	1763	393	82	376	0	52
2019^[9]	2673	5	1950	289	96	298	0	35
2020^[12]	1085	0	610	234	22	204	0	15
2021^[13]	798	0	390	182	30	187	0	9
合计	10085	19	6532	1671	297	1417	1	148

下载: 导出CSV

参考文献(43)

[1]	World Health Organization. Malaria[EB/OL]. (2022 – 07 – 26). https://www.who.int/news-room/fact-sheets/detail/malaria.
[2]	World Health Organization. Medicines for Malaria Venture, Back R, Severe malaria[J]. Tropical Medicine and International Health, 2014, 19(S1): 7 – 131.
[3]	World Health Organization. Global technical strategy for malaria 2016 – 2030, 2021 update[EB/OL]. (2021 – 07 – 19). https://www.who.int/publications/i/item/9789240031357.
[4]	朱国鼎, 高琪, 曹俊. 取不易守更难: 我国巩固消除疟疾成果面临的挑战[J]. 中国血吸虫病防治杂志, 2022, 34(2): 109 – 111, 114.
[5]	World Health Organization. From 30 million cases to zero: China is certified malaria-free by WHO[EB/OL]. (2021 – 06 – 30). https://www.who.int/news/item/30-06-2021-from-30-million-cases-to-zero-china-is-certified-malaria-free-by-who.
[6]	汤林华. 我国疟疾防治研究成就[J]. 中国寄生虫学与寄生虫病杂志, 1999, 17(5): 257 – 259.
[7]	卫生部, 发展改革委, 教育部, 等. 关于印发《中国消除疟疾行动计划(2010 — 2020年)》的通知[A]. 2010 – 05 – 26.
[8]	杨维中, 贾萌萌. 中国消除传染病的历史进程与展望[J]. 中华流行病学杂志, 2021, 42(11): 1907 – 1911. doi: 10.3760/cma.j.cn112338-20211016-00801
[9]	张丽, 丰俊, 夏志贵, 等. 2019年全国疟疾疫情特征分析及消除工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(2): 133 – 138. doi: 10.12140/j.issn.1000-7423.2020.02.001
[10]	张丽, 丰俊, 张少森, 等. 2017年全国消除疟疾进展及疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(3): 201 – 209.
[11]	张丽, 丰俊, 张少森, 等. 2018年全国疟疾疫情特征及消除工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(3): 241 – 247.
[12]	张丽, 丰俊, 涂宏, 等. 2020年全国疟疾疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(2): 195 – 199.
[13]	张丽, 易博禹, 夏志贵, 等. 2021年全国疟疾疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(2): 135 – 139.
[14]	World Health Organization. World malaria report 2021[EB/OL]. (2021 – 12 – 06). https://www.who.int/publications/i/item/9789240040496.
[15]	Malaria in 2022: a year of opportunity[J]. The Lancet, 2022, 399(10335): 1573.
[16]	Wangmo LD, Belo OMF, Penjor K, et al. Sustaining progress towards malaria elimination by 2025: lessons from Bhutan and Timor-Leste[J]. The Lancet Regional Health – Western Pacific, 2022, 22: 100429.2.
[17]	Kotepui M, Kotepui KU, De Jesus Milanez G, et al. Plasmodium spp. mixed infection leading to severe malaria: a systematic review and meta-analysis[J]. Scientific Reports, 2020, 10(1): 11068. doi: 10.1038/s41598-020-68082-3
[18]	Kojom Foko LP, Arya A, Sharma A, et al. Epidemiology and clinical outcomes of severe Plasmodium vivax malaria in India[J]. Journal of Infection, 2021, 82(6): 231 – 246. doi: 10.1016/j.jinf.2021.03.028
[19]	Greenwood B, Marsh K, Snow R. Why do some African children develop severe malaria?[J]. Parasitology Today, 1991, 7(10): 277 – 281. doi: 10.1016/0169-4758(91)90096-7
[20]	Paton RS, Kamau A, Akech S, et al. Malaria infection and severe disease risks in Africa[J]. Science, 2021, 373(6557): 926 – 931. doi: 10.1126/science.abj0089
[21]	Villarino NF, Lecleir GR, Denny JE, et al. Composition of the gut microbiota modulates the severity of malaria[J]. Proceedings of the National Academy of Sciences of the United States of America, 2016, 113(8): 2235 – 2240. doi: 10.1073/pnas.1504887113
[22]	Greenhalgh S, Chandwani V. Advocating an attack against severe malaria: a cost-effectiveness analysis[J]. BMC Public Health, 2020, 20(1): 17. doi: 10.1186/s12889-019-8141-y
[23]	de Laval F, Maugey N, Bonet d’Oléon A, et al. Increased risk of severe malaria in travellers during the COVID-19 pandemic[J]. Journal of Travel Medicine, 2021, 28(6): taab106. doi: 10.1093/jtm/taab106
[24]	Fried M, Duffy PE. Malaria during pregnancy[J]. Cold Spring Harbor Perspectives in Medicine, 2017, 7(6): a025551. doi: 10.1101/cshperspect.a025551
[25]	Walker PG, ter Kuile FO, Garske T, et al. Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study[J]. The Lancet Global Health, 2014, 2(8): e460 – e467. doi: 10.1016/S2214-109X(14)70256-6
[26]	Rahman MM, Abe SK, Rahman MS, et al. Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis[J]. The American Journal of Clinical Nutrition, 2016, 103(2): 495 – 504. doi: 10.3945/ajcn.115.107896
[27]	Tort J, Rozenberg P, Traoré M, et al. Factors associated with postpartum hemorrhage maternal death in referral hospitals in Senegal and Mali: a cross-sectional epidemiological survey[J]. BMC Pregnancy Childbirth, 2015, 15: 235. doi: 10.1186/s12884-015-0669-y
[28]	Duffy PE, Fried M. Pregnancy malaria: cryptic disease, apparent solution[J]. Memórias do Instituto Oswaldo Cruz, 2011, 106(S1): 64 – 69.
[29]	Garner P, Gülmezoglu AM. Drugs for preventing malaria in pregnant women[J]. Cochrane Database of Systematic Reviews, 2006(4): CD000169.
[30]	Bhatt S, Weiss DJ, Cameron E, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015[J]. Nature, 2015, 526(7572): 207 – 211. doi: 10.1038/nature15535
[31]	Mbacham WF, Ayong L, Guewo-Fokeng M, et al. Current situation of malaria in Africa[M]//Ariey F, Gay F, Ménard R. Malaria Control and Elimination. New York: Humana, 2019: 29 – 44.
[32]	Hemingway J. The role of vector control in stopping the transmission of malaria: threats and opportunities[J]. Philosophical Transactions of the Royal Society B:Biological Sciences, 2014, 369(1645): 20130431. doi: 10.1098/rstb.2013.0431
[33]	Ngufor C, N’Guessan R, Fagbohoun J, et al. Efficacy of the Olyset Duo net against insecticide-resistant mosquito vectors of malaria[J]. Science Translational Medicine, 2016, 8(356): 356ra121.
[34]	Mosha JF, Kulkarni MA, Lukole E, et al. Effectiveness and cost-effectiveness against malaria of three types of dual-active-ingredient long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs in Tanzania: a four-arm, cluster-randomised trial[J]. The Lancet, 2022, 399(10331): 1227 – 1241. doi: 10.1016/S0140-6736(21)02499-5
[35]	Meremikwu MM, Donegan S, Sinclair D, et al. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission[J]. Cochrane Database of Systematic Reviews, 2012, 2012(2): CD003756.
[36]	Cairns M, Ceesay SJ, Sagara I, et al. Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: case-control studies in 5 countries[J]. PLoS Medicine, 2021, 18(9): e1003727. doi: 10.1371/journal.pmed.1003727
[37]	Gilmartin C, Nonvignon J, Cairns M, et al. Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysis[J]. The Lancet Global Health, 2021, 9(2): e199 – e208. doi: 10.1016/S2214-109X(20)30475-7
[38]	Desai M, Hill J, Fernandes S, et al. Prevention of malaria in pregnancy[J]. The Lancet Infectious Diseases, 2018, 18(4): e119 – e132. doi: 10.1016/S1473-3099(18)30064-1
[39]	O’Leary K. A malaria vaccine at last[J]. Nature Medicine, 2021, 27(12): 2057.
[40]	World Health Organization. High burden to high impact: a targeted malaria response[EB/OL]. (2018 – 11 – 19). https://www.who.int/publications/i/item/WHO-CDS-GMP-2018.25.
[41]	Wu L, Van Den Hoogen LL, Slater H, et al. Comparison of diagno-stics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies[J]. Nature, 2015, 528(7580): S86 – S93. doi: 10.1038/nature16039
[42]	Mappin B, Cameron E, Dalrymple U, et al. Standardizing Plas-modium falciparum infection prevalence measured via microscopy versus rapid diagnostic test[J]. Malaria Journal, 2015, 14(1): 460. doi: 10.1186/s12936-015-0984-9
[43]	Yin JH, Yan H, Li M. Prompt and precise identification of various sources of infection in response to the prevention of malaria re-establishment in China[J]. Infectious Diseases of Poverty, 2022, 11(1): 45. doi: 10.1186/s40249-022-00968-y